Atlas Trials

18F-2-fluoro-2-deoxy-D-glucose in Positron Emission Tomography Computed Tomography

Clinical trial NCT04615156 · NOT_YET_RECRUITING

Trial details

NCT number
NCT04615156
Sponsor
Eastern Health, Canada
Status
NOT_YET_RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
Solitary Pulmonary NoduleOncology18F-2-fluoro-2-deoxy-D-glucoseAdverse Event
Start date
2020-11-01
Primary completion
2027-11-01
Enrollment
10000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.